|
SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform |
Medicines for Europe |
Tue, 09/18/2018 |
Health & Consumers |
|
CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court |
Medicines for Europe |
Thu, 09/20/2018 |
Health & Consumers |
|
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers |
Medicines for Europe |
Fri, 10/12/2018 |
Health & Consumers |
|
US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver |
Medicines for Europe |
Mon, 10/22/2018 |
Health & Consumers |
|
Driving local excellence, delivering European results |
Medicines for Europe |
Tue, 11/06/2018 |
Health & Consumers |
|
Value added medicines: Continuous innovation crucial to improve healthcare across Europe |
Medicines for Europe |
Wed, 11/21/2018 |
Health & Consumers |
|
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines |
Medicines for Europe |
Mon, 11/26/2018 |
Health & Consumers |
|
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). |
Medicines for Europe |
Wed, 11/28/2018 |
Health & Consumers |
|
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. |
Medicines for Europe |
Fri, 11/30/2018 |
Health & Consumers |
|
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! |
Medicines for Europe |
Tue, 12/04/2018 |
Health & Consumers |
|
Crucial European Parliament vote vastly improves SPC manufacturing waiver |
Medicines for Europe |
Thu, 01/24/2019 |
Health & Consumers |
|
Competition policy essential for access to medicines |
Medicines for Europe |
Tue, 01/29/2019 |
Health & Consumers |
|
Efficient use of pharmacovigilance data essential for patient safety |
Medicines for Europe |
Wed, 01/30/2019 |
Health & Consumers |
|
SPC manufacturing waiver cannot be derailed by foreign vested interests |
Medicines for Europe |
Thu, 02/07/2019 |
Health & Consumers |
|
New safeguards for patient safety as Falsified Medicines Directive comes into force |
Medicines for Europe |
Mon, 02/11/2019 |
Health & Consumers |
|
‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access |
Medicines for Europe |
Wed, 04/03/2019 |
Health & Consumers |
|
Ready to drive access to medicines |
Medicines for Europe |
Wed, 07/24/2019 |
Health & Consumers |
|
A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector |
Medicines for Europe |
Tue, 09/24/2019 |
Health & Consumers |
|
Immediately calls on new President of EU Commission to prioritise Healthcare |
Medicines for Europe |
Wed, 09/25/2019 |
Health & Consumers, InfoSociety |
|
EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement |
Medicines for Europe |
Mon, 09/30/2019 |
Health & Consumers |
|
Report identifies 9 key ingredients to improve access to medicines in the hospital setting |
Medicines for Europe |
Tue, 10/08/2019 |
Health & Consumers |
|
Biosimilar medicines: competition, sustainability and early* access on the agenda of DG GROW stakeholder workshop |
Medicines for Europe |
Wed, 10/30/2019 |
Health & Consumers |
|
Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal |
Medicines for Europe |
Thu, 11/14/2019 |
Health & Consumers |
|
‘Health revolution’: when smart innovation benefits patients |
Medicines for Europe |
Thu, 11/21/2019 |
Health & Consumers |
|
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe |
Medicines for Europe |
Thu, 11/28/2019 |
Health & Consumers |
|
Smart Pharmacovigilance Essential for Patient Safety |
Medicines for Europe |
Wed, 01/29/2020 |
Health & Consumers |
|
Time to modernise the eu pharmaceutical regulatory framework to deliver on access |
Medicines for Europe |
Thu, 01/30/2020 |
Health & Consumers, InfoSociety |
|
The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe |
Medicines for Europe |
Fri, 02/07/2020 |
Health & Consumers, InfoSociety |
|
Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy |
Medicines for Europe |
Tue, 03/03/2020 |
Health & Consumers |
|
Medicines for Europe statement on COVID-19 (‘coronavirus’) |
Medicines for Europe |
Fri, 03/13/2020 |
Health & Consumers |
